Skip to main content
Log in

A new model of osteopenia using ectopically induced bone: effects of parathyroid hormone and estradiol on bone turnover in induced bone

  • Session VII: Pathogenesis: Bone Cells, Hormones And Growth Factors
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bingham PJ, Brazell IA, Owen M. The effect of parathyroid extract on cellular activity and plasma calcium levels in vivo. J Endocrinol 1969;45:387–400.

    Google Scholar 

  2. Selye H. On the stimulation of new bone formation with parathyroid extract and irradiated ergosterol. Endocrinology 1932;16:547–58.

    Google Scholar 

  3. Kalu DN, Pennock J, Doyle FH, Foster GV. Parathyroid hormone and experimental osteosclerosis. Lancet 1970;2:1363–6.

    Google Scholar 

  4. Tam CS, Heersche JNM, Murray TM, Parsons JA. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration. Endocrinology 1982;110:506–12.

    Google Scholar 

  5. Podbesek R, Edouard C, Meunier PJ, Parsons JA, Reeve J, Stevenson RW, Zanelli JM. Effects of two treatment regimens with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in grayhounds. Endocrinology 1983;112:1000–6.

    Google Scholar 

  6. Richelson LS, Wahner HW, Melton LJ, Riggs BL. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med 1984;311:1273–5.

    Google Scholar 

  7. Nilas L, Christiansen C. Bone mass and its relationship to age and the menopause. J Clin Endocrinol Metab 1987;65:697–702.

    Google Scholar 

  8. Wromski TJ, Cintron M, Doherty L, Dann LM. Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 1988;123:681–6.

    Google Scholar 

  9. Amitami K, Nakata Y, Stevence J. Bone induction by lyophilized osteosarcoma in mice. Calcif Tissue Res 1974;16:305–13.

    Google Scholar 

  10. Takaoka K, Yoshikawa H, Shimizu N, One K, Amitami K, Nakata Y, Sakamoto Y. Purification of a bone-inducing substance (osteogenic factor) from a murine osteosarcoma. Biomed Res 1981;2:466–71.

    Google Scholar 

  11. Yoshikawa H, Hasimoto J, Masuhara K, Takaoka K, Ona K. Inhibition by tumor necrosis factor of induction of ectopic bone formation by osteosarcoma-derived bone-inducing substance. Bone 1988;9:391–6.

    Google Scholar 

  12. Shima M, Tanaka H, Norma AW, Yamaoka K, Yoshikawa H, Tanaka K, et al. 23 (S),25(R)-1,25-dihydroxyvitaminD3-26,23-lactone stimulates murine bone formation in vivo. Endocrinolog 1990;126:832–6.

    Google Scholar 

  13. Hashimoto J, Takaoka K, Yoshikawa H, Miyamoto S, Suzuki S, Ono K. Preservation of ectopically induced bone in the mouse by estradiol. Bone 1991;12:249–55.

    Google Scholar 

  14. Dunn TB, Andervont HB. Histology of some neoplasmas and non-neoplastic lesions found in wild mice maintained under laboratory conditions. J Natl Cancer Inst 1963;31:873–901.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hashimoto, J., Takaoka, K., Yoshikawa, H. et al. A new model of osteopenia using ectopically induced bone: effects of parathyroid hormone and estradiol on bone turnover in induced bone. Osteoporosis Int 3 (Suppl 1), 128–131 (1993). https://doi.org/10.1007/BF01621886

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01621886

Keywords

Navigation